Waltham, MA, United States of America

Dingwei Yu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Natick, MA (US) (2012)
  • Waltham, MA (US) (2008 - 2014)

Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dingwei Yu

Introduction

Dingwei Yu is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 5 patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

Dingwei Yu's latest patents include the invention of Pyrazolylaminopyridine derivatives, which are useful as kinase inhibitors. This invention relates to novel compounds having the formula (I) and their pharmaceutical compositions. These compounds are designed to provide effective treatment options for cancer, showcasing the innovative nature of his work.

Career Highlights

Dingwei Yu is currently associated with AstraZeneca, a leading global biopharmaceutical company. His role at AstraZeneca allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in creating novel compounds has positioned him as a valuable asset in the fight against cancer.

Collaborations

Dingwei Yu collaborates with talented professionals in his field, including Michelle Lamb and Tao Wang. These collaborations enhance the research and development process, leading to innovative solutions in cancer treatment.

Conclusion

Dingwei Yu's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his commitment to advancing cancer treatment. His work at AstraZeneca and collaborations with other professionals further emphasize the importance of teamwork in achieving significant breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…